GLSI financials

Greenwich LifeSciences (GLSI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

GLSI income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$19.45M-$19.36M-1.43
2024––-$17.64M-$17.41M-1.34
2023––-$9.33M-$8.89M-0.69
2022––-$8.04M-$7.83M-0.61
2021––-$4.60M-$4.57M-0.35
2020––-$1.86M-$1.86M-0.20